Additionally, reduced levels of Rad51 expression by siRNA are shown to increase sensitivity to PARPi in human gastric cancer cells, and restoration of Rad51 via plasmid transfection attenuated drug sensitivity [44]. Here, RAD51 is linked to gastric cancer.